Vcn Enhancer Compositions And Methods Of Using The Same - EP4151720

The patent EP4151720 was granted to Bluebird BIO on Aug 7, 2024. The application was originally filed on Feb 10, 2017 under application number EP22191258A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4151720

BLUEBIRD BIO
Application Number
EP22191258A
Filing Date
Feb 10, 2017
Status
Granted And Under Opposition
Jul 5, 2024
Grant Date
Aug 7, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSMay 7, 2025MATHYS & SQUIREADMISSIBLE

Patent Citations (41) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2004092535
DESCRIPTIONUS2004209878
DESCRIPTIONUS2006247214
DESCRIPTIONUS2015307867
DESCRIPTIONUS4873192
DESCRIPTIONUS5460964
DESCRIPTIONUS5635387
DESCRIPTIONUS5677136
DESCRIPTIONUS568159
DESCRIPTIONUS5716827
DESCRIPTIONUS5750397
DESCRIPTIONUS5759793
DESCRIPTIONUS5861488
DESCRIPTIONUS5864029
DESCRIPTIONUS5869039
DESCRIPTIONUS5877288
DESCRIPTIONUS5994136
DESCRIPTIONUS6013516
DESCRIPTIONUS6013769
DESCRIPTIONUS6051402
DESCRIPTIONUS6057117
DESCRIPTIONUS6608063
DESCRIPTIONUS6610719
DESCRIPTIONUS6670323
DESCRIPTIONUS6682907
DESCRIPTIONUS6747037
DESCRIPTIONUS7901671
DESCRIPTIONUS8858928
DESCRIPTIONUS9061031
DESCRIPTIONUS9068199
DESCRIPTIONWO0038663
DESCRIPTIONWO0112596
DESCRIPTIONWO02088346
DESCRIPTIONWO2006047476
DESCRIPTIONWO2007071456
DESCRIPTIONWO2007112084
DESCRIPTIONWO2010108028
OPPOSITIONUS2013004471
OPPOSITIONWO2014026110
SEARCHUS2014234278
SEARCHUS2015064788

Non-Patent Literature (NPL) Citations (73) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ARUMUGAMMALIK, Hematology Am Soc Hematol Educ Program, (20100000), no. 1, pages 445 - 50-
DESCRIPTION- BEARD et al., J Clin Invest, (20100000), vol. 120, no. 7, pages 2345 - 2354-
DESCRIPTION- BELL et al., Cell, (19990000), vol. 98, page 387-
DESCRIPTION- BURGESS-BEUSSE et al., Proc. Natl. Acad. Sci., USA, (20020000), vol. 99, page 16433-
DESCRIPTION- CHUNG et al., Cell, (19930000), vol. 74, page 505-
DESCRIPTION- CHUNG et al., PNAS, (19970000), vol. 94, page 575-
DESCRIPTION- CLEVER et al., J. of Virology, (19950000), vol. 69, no. 4, pages 2101 - 2109-
DESCRIPTION- CORNETTA et al., Cancer Gene Ther., (20060000), vol. 13, no. 9, pages 886 - 895-
DESCRIPTION- CULLEN et al., Cell, (19910000), vol. 58, page 423-
DESCRIPTION- CULLEN et al., J. Virol., (19910000), vol. 65, page 1053-
DESCRIPTION- DUNBAR et al., Hum Gene Ther, (19980000), vol. 9, no. 17, pages 2629 - 2640-
DESCRIPTION- FINOTTI et al., Journal of BloodMedicine, (20150000), vol. 6, pages 69 - 85-
DESCRIPTION- HOBAN et al., Blood, (20160000), vol. 127, pages 839 - 848-
DESCRIPTION- HUANGYEN, Mol. Cell. Biol., (19950000), vol. 5, page 3864-
DESCRIPTION- IMREN et al., Proc Natl Acad Sci USA., (20020000), vol. 99, no. 22, pages 14380 - 14385-
DESCRIPTION- IRIONS et al., Nature, (20070000), vol. 25, pages 1477 - 1482-
DESCRIPTION- JACKSON et al., Trends Biochem Sci, (19900000), vol. 15, no. 12, pages 477 - 83-
DESCRIPTION- JACKSONKAMINSKI, RNA, (19950000), vol. 1, no. 10, pages 985 - 1000-
DESCRIPTION- KOZAK, Cell, (19860000), vol. 44, no. 2, pages 283 - 92-
DESCRIPTION- KOZAK, Nucleic Acids Res., (19870000), vol. 15, no. 20, pages 8125 - 48-
DESCRIPTION- KUNKEL et al., Methods in Enzymol, (19870000), vol. 154, pages 367 - 382-
DESCRIPTION- KUNKEL, Proc. Natl. Acad. Sci. USA., (19850000), vol. 82, pages 488 - 492-
DESCRIPTION- KUTNER et al., BMC Biotechnol, (20090000), vol. 9, page 10-
DESCRIPTION- KUTNER et al., BMC Biotechnol., (20090000), vol. 9, page 10-
DESCRIPTION- KUTNER et al., Nat. Protoc., (20090000), vol. 4, no. 4, pages 495 - 505-
DESCRIPTION- LANDY, Current Opinion in Biotechnology, (19930000), vol. 3, pages 699 - 707-
DESCRIPTION- LEVASSEUR et al., Blood, (20030000), vol. 102, pages 4312 - 4319-
DESCRIPTION- LIU et al., Genes Dev., (19950000), vol. 9, page 1766-
DESCRIPTION- LOWY et al., Cell, (19900000), vol. 22, pages 817 - 823-
DESCRIPTION- MAGUIRE et al., N Engl J Med, (20080000), vol. 358, no. 21, page 2240-
DESCRIPTION- MALIK et al., Ann NYAcad Sci., (20050000), vol. 1054, pages 238 - 249-
DESCRIPTION- MAY et al., Nature, (20000000), vol. 357, no. 6791, pages 455 - 460-
DESCRIPTION- MILSOM et al., Cancer Res., (20080000), vol. 68, no. 15, pages 6171 - 6180-
DESCRIPTION- N. R. LANDAU et al., J. Virol., (19920000), vol. 66, pages 5110 - 5113-
DESCRIPTION- PAWLIUK et al., Science, (20010000), vol. 294, no. 5550, pages 2368 - 2371-
DESCRIPTION- PESTINA et al., Molecular Therapy, (20090000), vol. 17, no. 2, pages 245 - 252-
DESCRIPTION- SANTONI DE SIONALDINI, Methods Mol Biol., (20090000), vol. 506, pages 59 - 70-
DESCRIPTION- SAUER, B., Current Opinion in Biotechnology, (19940000), vol. 5, pages 521 - 527-
DESCRIPTION- SCOTTDEFRANCESCO, Nature Biotechnology, (20160000), vol. 34, pages 600 - 607-
DESCRIPTION- SIRIN et al., Gene, (20030000), vol. 323, page 67-
DESCRIPTION- WIGLER et al., Cell, (19770000), vol. 11, pages 223 - 232-
DESCRIPTION- Y. SONEOKA et al., Nucl. Acids Res., (19950000), vol. 23, pages 628 - 633-
DESCRIPTION- ZENNOU et al., Cell, (20000000), vol. 101, page 173-
DESCRIPTION- ZHAN et al., Hum. Genet., (20010000), vol. 109, page 471-
DESCRIPTION- ZUFFEREY et al., J. Virol., (19990000), vol. 73, page 2886-
OPPOSITION- Anonymous, "Hemangioblast", Wikipedia, (20150901), Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=Hemangioblast&oldid=678911346, XP093278583-
OPPOSITION- Anonymous, "Kolliphor ® P 407 Geismar - Technical Information", BASF; WF-No. DAWF-2019-0855, (20200301), XP093278593-
OPPOSITION- Anonymous, "Poloxamere", Europaisches Arzneibuch 7th Edition, (20110101), pages 4177 - 4178, XP055933739-
OPPOSITION- D29 - Experimental report-
OPPOSITION- Heffner Garrett C., Lauryn Christiansen, John Pierciey, Byoung Ryu, Glenna Ford, Robert Kutner, Mitchell Finer, Gabor Veres, "Abstract 683. PGE2 Increases Lentiviral Vector Transduction Efficiency of Human HSC ", Molecular Therapy, (20140501), vol. 22, no. 1, page S264, XP093278581-
OPPOSITION- Hoban, Et Al, "Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease", Blood, (20160112), vol. 127, no. 7, pages 839 - 848, XP055510604-
OPPOSITION- Thimmasandra Narayanappa Athmaram, "A rapid cell-based assay for determining poloxamer quality in CHO suspension cell culture", BioTechniques, (20190901), vol. 67, no. 3, pages 98 - 109, XP055878516-
OPPOSITION- Cao Nian, Yao Zhong‐xiang, "The Hemangioblast: From Concept to Authentication", The anatomical record, American Association of Anatomists, Hoboken, NJ : Wiley-Liss, Hoboken, NJ : Wiley-Liss , (20110401), vol. 294, no. 4, doi:10.1002/ar.21360, ISSN 1932-8486, pages 580 - 588, XP093278597
OPPOSITION- Ines Höfig, Michael J. Atkinson, Sabine Mall, Angela M. Krackhardt, Christian Thirion, Nataša Anastasov, "Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors", The Journal of Gene Medicine, John Wiley & Sons, (20120801), vol. 14, no. 8, doi:10.1002/jgm.2653, ISSN 1099498X, pages 549 - 560, XP055061427
OPPOSITION- KATAKURA H, ET AL, "Improvement of retroviral vectors by coating with poly(ethylene glycol)-poly(L-lysine) block copolymer (PEG-PLL)", The Journal of Gene Medicine, John Wiley & Sons, Inc, US, US , (20040401), vol. 6, no. 4, doi:10.1002/JGM.519, ISSN 1099-498X, pages 471 - 477, XP002582739
OPPOSITION- Tomatsu Shunji; Azario Isabella; Sawamoto Kazuki; Pievani Alice Silvia; Biondi Andrea; Serafini Marta, "Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?", JOURNAL OF INHERITED METABOLIC DISEASE., KLUWER, DORDRECHT., NL, NL , (20151117), vol. 39, no. 2, doi:10.1007/s10545-015-9900-2, ISSN 0141-8955, pages 189 - 202, XP035627513
OPPOSITION- Porter, C.J.H. ; Moghimi, S.M. ; Davies, M.C. ; Davis, S.S. ; Illum, L., "Differences in the molecular weight profile of poloxamer 407 affect its ability to redirect intravenously administered colloids to the bone marrow", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (19820630), vol. 83, no. 1-3, doi:10.1016/0378-5173(82)90033-3, ISSN 0378-5173, pages 273 - 276, XP023724764
OPPOSITION- Anonymous, "CD34", Wikipedia, doi:10.1016/0888-, (20160130), Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=CD34&oldid=702465789, XP093278577
OPPOSITION- Neschadim, A. McCart, J.A. Keating, A. Medin, J.A., "A Roadmap to Safe, Efficient, and Stable Lentivirus-Mediated Gene Therapy with Hematopoietic Cell Transplantation", BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, KLUGE CARDEN JENNINGS PUBLISHING, CHARLOTTESVILLE, VA, US, US , (20071118), vol. 13, no. 12, doi:10.1016/j.bbmt.2007.09.014, ISSN 1083-8791, pages 1407 - 1416, XP022348841
OPPOSITION- Strappe, P.M. Hampton, D.W. Cachon-Gonzalez, B. Fawcett, J.W. Lever, A., "Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20051001), vol. 61, no. 3, doi:10.1016/j.ejpb.2005.06.006, ISSN 0939-6411, pages 126 - 133, XP005106553
OPPOSITION- Kate L. Dishart, Et Al.,, "Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy", Journal of Molecular and Cellular Cardiology, (20030101), vol. 35, doi:10.1016/S0022-2828(03)00136-6, pages 739 - 748, XP055424972
OPPOSITION- Alexander Kabanov, Jian Zhu, Valery Alakhov, "Pluronic Block Copolymers for Gene Delivery", Advances in Genetics, Academic Press, US, US , (20050101), vol. 53, doi:10.1016/S0065-2660(05)53009-8, ISSN 0065-2660, pages 231 - 261, XP002679846
OPPOSITION- Heffner Garrett C; Christiansen Lauryn; Pierciey Francis J Jr; Kutner Robert; Finer Mitchell; Veres Gabor, "PGE2 Increases Lentiviral Vector Transduction Efficiency of Human HSC", BIOLOGICAL ABSTRACTS, (20130601), XP002716621
OPPOSITION- Klapwijk Jan C., Del Rio Espinola Alberto, Libertini Silvana, Collin Philippe, Fellows Mick D., Jobling Susan, Lynch Anthony M., Martus Hansjoerg, Vickers Catherine, Zeller Andreas, Biasco Luca, Brugman Martijn H., Bushmann Frederic D., Cathomen Toni, Ertl Hildegrund C.J., Gabriel Richard, Gao Guangping, Jadlowsky Julie K., Kimber Ian, Lanz Thomas A., Levine Bruce L., Micklethwaite Kenneth P., Onodera Masafumi, Pizzurro Daniella M., Reed Simon, Rothe Michael, Sabatino Denise E., Salk Jesse J., Schambach Axel, Themis Michael, Yuan Jing, "Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (20240801), vol. 35, no. 15-16, doi:10.1089/hum.2024.033, ISSN 1043-0342, pages 527 - 542, XP093278587
OPPOSITION- KHATTAK SARWAT F, BHATIA S R, ROBERTS S C, "Pluronic F127 as a cell encapsulation material: utilization of membrane-stabilizing agents.", Tissue Engeneering, LARCHMONT, NY, US, US , (20050501), vol. 11, no. 5-6, doi:10.1089/ten.2005.11.974, ISSN 1076-3279, pages 974 - 983, XP002676374
OPPOSITION- Anonymous, "Book of Abstracts", Journal of Inborn Errors of Metabolism and Screening, (20160729), vol. 4, doi:10.1177/2326409816653634, ISSN 2326-4098, page 232640981665363, XP093278610
OPPOSITION- Visigalli Ilaria, Delai Stefania, Politi Letterio S, Domenico Carmela Di, Cerri Federica, Mrak Emanuela, D'isa Raffaele, Ungaro Daniela, Stok Merel, Sanvito Francesca, Mariani Elisabetta, Staszewsky Lidia, Godi Claudia, Russo Ilaria, Cecere Francesca, Del Carro Ubaldo, Rubinacci Alessandro, Brambilla Riccardo, Quattrini Angelo, Natale Paola Di, Ponder Katherine, Naldini Luigi, Biffi Alessandra, "Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model", Blood, (20101209), vol. 116, no. 24, doi:10.1182/blood-2010-04-278234, pages 5130 - 5139, XP093278605
OPPOSITION- Krishnamoorthy B, Critchley Wr, Barnard Jb, Waterworth Pd, Caress Ac, Fildes J, Yonan N, "Validation of the endothelial staining markers CD31 and CD34 in immunohistochemistry of the long saphenous vein", Journal of Cardiothoracic Surgery, BioMed Central Ltd, Lo, Lo , (20151201), vol. 10, no. S1, doi:10.1186/1749-8090-10-S1-A321, ISSN 1749-8090, page A321, XP093278600
OPPOSITION- Millington Michelle, Arndt Allison, Boyd Maureen, Applegate Tanya, Shen Sylvie, "Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34+ Hematopoietic Stem/Progenitor Cells", PLoS ONE, (20090730), vol. 4, no. 7, doi:10.1371/journal.pone.0006461, page e6461, XP055946049
OPPOSITION- Olivier Negre, Bartholomae Cynthia, Beuzard Yves, Cavazzana Marina, Christiansen Lauryn, Courne Céline, Deichmann Annette, Denaro Maria, De Dreuzy Edouard, Finer Mitchell, Fronza Raffaele, Gillet-Legrand Béatrix, Joubert Christophe, Kutner Robert, Leboulch Philippe, Maouche Leïla, Paulard Anaïs, Pierciey Francis J, Jr, Rothe Michael, Ryu Byoung, Schmidt Manfred, Von Kalle Christof, Payen Emmanuel, Veres Gabor, "Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of -Thalassemia and Sickle Cell Disease", Current Gene Therapy, (20150101), vol. 15, doi:10.2174/1566523214666141127095336, pages 64 - 81, XP055393858
OPPOSITION- Filipek-Gorzała Jadwiga, Kwiecińska Patrycja, Szade Agata, Szade Krzysztof, "The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies", Frontiers in Oncology, Frontiers Media S.A., vol. 14, doi:10.3389/fonc.2024.1308709, ISSN 2234-943X, XP093278612
OPPOSITION- Gray Steven J; Woodard Kenton T; Samulski R Jude, "Viral vectors and delivery strategies for CNS gene therapy.", Therapeutic delivery, England, England, (20101001), vol. 1, no. 4, doi:10.4155/tde.10.50, ISSN 2041-5990, pages 517 - 534, XP009173719
SEARCH- INES H?FIG ET AL, "Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors", THE JOURNAL OF GENE MEDICINE, (20120801), vol. 14, no. 8, doi:10.1002/jgm.2653, ISSN 1099-498X, pages 549 - 560, XP055061427 [A] 1-15 * page 556, column r, paragraph l - page 558, column l *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents